Does Bladder Instillation Reduce Time to Discharge After Sling Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02277288|
Recruitment Status : Recruiting
First Posted : October 29, 2014
Last Update Posted : July 18, 2018
|Condition or disease||Intervention/treatment||Phase|
|Stress Urinary Incontinence||Other: Filled bladder arm||Not Applicable|
Urinary stress incontinence affects 4-35% of women. Due to the large economic impact and prevalence of the disease, urinary incontinence is a significant public health issue. With rising healthcare costs it has become increasingly important to manage patient care in the most cost-efficient manner. Considering the increasing number of women undergoing mid-urethral sling procedures, it is imperative that perioperative care is streamlined in order to minimize cost. The Cedars-Sinai Center for Continence and Women's Pelvic Health instituted a new practice pattern that enables patients to complete a voiding trial sooner after surgery compared to previous practice patterns thus allowing patients to be discharged earlier and ultimately decreasing cost. The purpose of this study is to compare the previous voiding trial practice (emptying the bladder at the end of surgery) versus the newly instituted practice (filling with bladder with 250cc) and perform a cost benefit analysis to determine if there is a significant decrease in recovery and discharge time. Both of these practices fall under the standard-of-care. However, of the several standard-of-care procedures, none have been tested for superiority. To date there are no randomized control trials that address this issue in female mid-urethral sling surgery.
Boccola et al showed in a study of 60 men who had undergone transurethral resection of the prostate (TURP) that by instilling the bladder with 300-500cc of warm saline the time to void was significantly decreased compared to standard indwelling catheter removal. It was also shown that the bladder instillation group had a significantly shorter time to discharge. The study suggested that given the significant decrease in time in recovery, this would be an ideal practice for many other outpatient procedures. Willson, et al, in another randomized trial of 75 men who underwent TURP, found that bladder infusion allowed early decision-making for discharge on the second postoperative day. Finally, McAchran and Goldman found that when patients were managed using a fast-track regimen in the outpatient setting after mid-urethral sling procedures the median time from the recovery area to discharge was less than 3 hours.
For our study, if a significant decrease in the time to discharge with the newly instituted practice pattern is demonstrated, then this practice can be adopted by other institutions and become the new standard of care to help decrease both cost and patient time in the hospital.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||250 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Does Intraoperative Bladder Instillation Decrease Outpatient Recovery Time After Mid-Urethral Sling|
|Study Start Date :||December 2011|
|Estimated Primary Completion Date :||December 2025|
|Estimated Study Completion Date :||December 2025|
No Intervention: Emptied bladder arm
No instillation of fluid into bladder.
Experimental: Filled bladder arm
Instilled bladder with fluid.
Other: Filled bladder arm
Bladder to be instilled with 200 cc fluid during cystoscopy and no catheter for all mid-urethral sling procedures.
- Time between surgery and discharge home [ Time Frame: 2 Days ]Will analyze if the time to discharge is shorter in those patients who have had bladder instillation versus those with an indwelling catheter postoperatively.
- Hospital charges [ Time Frame: 1 Month ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02277288
|Contact: Jennifer Anger, MD, MPH||3103852992|
|United States, California|
|Cedars-Sinai Medical Center||Recruiting|
|Beverly Hills, California, United States, 90211|
|Contact: Jennifer Anger, MD, MPH 310-385-2992|
|Principal Investigator: Jennifer Anger, MD, MPH|
|Principal Investigator:||Jennifer Anger, MD, MPH||Cedars-Sinai Medical Center|